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A B S T R A C T
Exposure to mixtures of endocrine disrupting chemicals may contribute to the rising incidence of hormone-
related diseases in humans. Real-life mixtures are complex, comprised of chemicals with mixed modes of action,
and essential knowledge is often lacking on how to group such chemicals into cumulative assessment groups,
which is an essential prerequisite to conduct a chemical mixture risk assessment.
We investigated if mixtures of chemicals with diverse endocrine modes of action can cause mixture effects on
hormone sensitive endpoints in developing and adult rat offspring after perinatal exposure. Wistar rats were
exposed during pregnancy and lactation simultaneously to either bisphenol A and butylparaben (Emix), die-
thylhexyl phthalate and procymidone (Amix), or a mixture of all four substances (Totalmix). In male offspring,
the anogenital distance was significantly reduced and nipple retention increased in animals exposed to Amix and
Totalmix, and the mixture effects were well approximated by the dose addition model. The combination of Amix
and Emix responded with more marked changes on these and other endocrine-sensitive endpoints than each
binary mixture on its own. Sperm counts were reduced by all exposures. These experimental outcomes suggest
that the grouping of chemicals for mixture risk assessment should be based on common health outcomes rather
than only similar modes or mechanisms of action. Mechanistic-based approaches such as the concept of Adverse
Outcome Pathway (AOP) can provide important guidance if both the information on shared target tissues and
the information on shared mode/mechanism of action are taken into account.
1. Introduction
Chemical exposure is suspected to contribute to a high prevalence of
endocrine disorders in the Western world (WHO/UNEP, 2013). This
calls for an improved understanding of how exposure to complex che-
mical mixtures in our everyday life may lead to adverse health effects
such as hormone-dependent cancers, fertility problems and congenital
malformations. Risk assessment of chemicals with mixed modes and
mechanisms of action presents an unsolved challenge.
Over the last decades, our understanding of combined exposures to
environmental chemicals and how to assess the humans and the en-
vironment has improved substantially (Kortenkamp and Faust, 2018).
Consequently, scientific and regulatory focus has shifted from only
performing risk assessments for an individual substance towards
performing Mixture Risk Assessment (MRA), where the risk of com-
bined exposures to multiple chemicals is assessed (Boberg et al., 2019;
Bopp et al., 2018; EC European Commision, 2012; EFSA, 2019;
Howdeshell et al., 2017).
There is clear experimental evidence that mixture effects can be
anticipated for chemicals with similar mechanisms of action even at
doses where each chemical is ineffective (Christiansen et al., 2012,
2009; Conley et al., 2018, 2016; Hass et al., 2012, 2007; Metzdorff
et al., 2007; Silva et al., 2002). Experiments show that cumulative ef-
fects of chemicals with the same molecular initiating events (e.g. AR
antagonism) follow the dose-addition principles (Christiansen et al.,
2008; Hannas et al., 2011; Hass et al., 2007; Howdeshell et al., 2015,
2008b, 2007; Metzdorff et al., 2007; Rider et al., 2009). Additionally,
dose-additive effects on androgen sensitive endpoints have been
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demonstrated after exposure to anti-androgenic compounds with dif-
ferent mechanisms of action (Christiansen et al., 2009; Conley et al.,
2018) and even for multi-causal effects such as reduced birth weight
(Hass et al., 2017). This evidence for mixture effects of chemicals with
different mechanisms of action implies that mixture risk assessment
should go beyond grouping based on shared mechanisms of action.
In the present paper, we propose to group chemicals based on a
common target tissue rather than common mechanisms of action. In
line with this, EFSA and ECHA propose tiered strategies for component-
based mixture risk assessment, where at the first tiers chemicals are
grouped on basis of shared effects on target organs, and at more refined
tiers chemicals are grouped based on mode or mechanism of action
(ECHA, 2017; EFSA, 2019, 2013).
In developmental and reproductive toxicity studies, commonly used
predictive endpoints for male reproductive disorders are the anogenital
distance (AGD) and nipple retention (NR). Both are considered an-
drogen-sensitive and are expected to be primarily affected by anti-an-
drogens (Christiansen et al., 2008; Schwartz et al., 2019). Other end-
points such as sperm count and development of testis, mammary gland
and prostate can be influenced via both androgen and estrogen sensitive
pathways.
Importantly, numerous EDCs act via more than one endocrine me-
chanism of action, thus the focus on common outcomes at first tiers
avoids the complicated task to “classify” chemicals by molecular me-
chanisms.
We propose that four EDCs with mixed modes/mechanisms of ac-
tion will act additively on endocrine sensitive endpoints. Two anti-an-
drogens, di-(2-ethylhexyl) phthalate (DEHP) and procymidone, are well
known to reduce both male anogenital distance (AGD) and sperm
count, and our recent studies showed similar effects of BPA and bu-
tylparaben (Fig. 1, Boberg et al., 2016; Christiansen et al., 2014; Hass
et al., 2016). Additive effects on these and other endocrine sensitive
target organs may occur via a shared network of adverse outcome
pathways (AOP) as illustrated in Fig. 2. In a recent paper, (Kortenkamp,
2020) also suggests to apply information on adverse outcome pathways
for grouping of chemicals affecting the male reproductive system.
In a proof of principle study, we, therefore, examined male re-
productive toxicity targets in rats perinatally exposed to mixtures of
Bisphenol A (BPA), butylparaben, di-(2-ethylhexyl) phthalate (DEHP)
and procymidone. These four compounds have been reported to act via
different endocrine modes of action, as DEHP reduces testosterone
production during critical stages of sex differentiation in male rat fe-
tuses (Foster et al., 2006; Parks et al., 2000; Wilson et al., 2004), pro-
cymidone is an AR antagonist binding to mammalian androgen re-
ceptors (Hass et al., 2007; Ostby et al., 1999; Wolf et al., 1999), and
BPA and butylparaben are best known for their estrogenic properties
(Byford et al., 2002; Routledge et al., 1998; Wetherill et al., 2007).
A straightforward approach for the MRA of these four compounds
would be to allocate them into two distinct assessment groups, with
BPA and butylparaben as “estrogens” and BPA and DEHP as “anti-an-
drogens”. In addition to the fact that both estrogens and androgens can
affect male reproductive tissues, experimental evidence suggests that
these compounds have more than one endocrine mechanism of action.
For butylparaben, our finding of reduced male AGD and sperm count
(Boberg et al., 2016) is in line with results from several other studies
showing reduced sperm counts in developmentally exposed male rats
(KANG et al., 2002; Yang et al., 2016; Zhang et al., 2014). However,
there are also studies reporting no effects on AGD for butylparaben
(Boberg et al., 2008; Guerra et al., 2016; KANG et al., 2002; Taxvig
et al., 2008) Reductions in male AGD and sperm count in our BPA study
(Christiansen et al., 2014; Hass et al., 2016) is not corroborated by
other studies using similar doses (Ferguson et al., 2011; Howdeshell
et al., 2008a; Takagi et al., 2004; Tinwell et al., 2002; Tyl et al., 2008)
At high doses, BPA is well-known to induce male reproductive
toxicity in studies involving developmental exposure, however, at lower
doses, the evidence is controversial, with considerable inter-study
variation in quality and outcomes (EFSA, 2015). Moreover, numerous in
vitro studies have demonstrated a weak anti-androgenic activity for BPA
and butylparaben (Chen et al., 2007; Kjærstad et al., 2010; Reif et al.,
2010; Rosenmai et al., 2014; Satoh et al., 2005).
In the current study we exposed pregnant and lactating rats to a
binary mixture of DEHP and Procymidone (Amix), a binary mixture of
BPA and butylparaben (Emix), and a combination of all four com-
pounds (Totalmix) and we evaluated both early androgen-sensitive
endpoints (AGD, nipple retention, reproductive organ weights) and
late-life effects such as sperm count. Doses were selected based on our
previous rat studies showing effects on a common adverse endpoint,
male anogenital distance (AGD) (Boberg et al., 2016; Christiansen et al.,
2010; Christiansen et al., 2014; Hass et al., 2012, 2007), see Fig. 1. The
lowest dose of each compound corresponded to around 5% reduction in
AGD in previous studies (Emix-low, Amix-low, Totalmix-low). The
highest doses were twice the lowest dose.
Acknowledging that androgens play a key role not only in early life
sexual development but also during puberty (Monosson et al., 1999),
we wanted to investigate if exposure to the same mixtures of EDs both
perinatally and during puberty would lead to an increased sensitivity
for adverse effects later in life. This part of the study design was in-
spired by a study showing how adverse effects of perinatal BPA ex-
posure in mice were exacerbated by additional pubertal BPA exposure
(Rubin et al., 2017).
Overall, with this developmental study, we aimed to investigate:
1. Can estrogenic compounds enhance the effects of anti-androgenic
substances?
2. Can the concept of dose-addition be used to describe the observed
responses from the four-compound mixture, and for which endpoints?
3. Can historical single-compound data be used to predict dose-ad-
ditive mixture responses?
4. Can a re-dosing of the animals during puberty influence adult
health outcomes?
2. Materials and methods
2.1. Chemicals and mixtures
BPA (Bisphenol A) (purity > 99.5%, CAS no. 80–05-7),
Butylparaben, (purity 99%, CAS no. 94–26-8, (no. W220302-1 kg)) and
Procymidone (purity 99.9%, CAS no. 32809–16-8, from Fluka no.
36640–250 mg-R) were purchased from Sigma-Aldrich (Brøndby,
Denmark). DEHP (purity 99%, CAS no. 117–81-7, from Merck no.
8.2174.1000) was purchased from VWR- Bie & Berntsen, (Herlev,
Denmark). Corn oil purchased in glass bottles from Sigma-Aldrich
(Brøndby, Denmark) was used as both negative control and vehicle. The
mixture solutions used for dosing were stored in glass bottles at room
temperature, protected from light, and continuously stirred during the
dosing period.
For the chemical analysis of Procymidone, we obtained Acetonitrile,
methanol, formic acid and 25% ammonium hydroxide, all of LC-MS
grade, and ethyl acetate from Sigma Aldrich, Schneldorf, Germany.
Isolute bulk C-18 sorbent was obtained from Biotage, Sweden, the
sorbent was washed with acetonitrile and ethyl acetate and dried prior
to use. Water was purified on a Milli Q system, Millipore Corporation,
US. Stock solutions of Procymidon of 1 mg/ml were prepared in DMSO.
2.2. Animals and exposure
Animal experiments were carried out at the DTU National Food
Institute (Mørkhøj, Denmark) facilities. Ethical approval was given by
the Danish Animal Experiments Inspectorate. The authorization
number given is 2012-15-2934-00089 C4. The experiments were
overseen by the National Food Institutes in-house Animal Welfare
Committee for animal care and use.
126 time-mated nulliparous, young adult Wistar rats (HanTac:WH,
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SPF, Taconic Europe, Ejby, Denmark) were supplied at gestation day
(GD) 3 of pregnancy. The day when a vaginal plug was detectable was
designated as gestation day (GD) 1, and independently of the actual day
of delivery, the expected day of delivery GD 23 was designated as pup
day (PD) 1. The animals were housed in pairs until GD 17, and there-
after alone, under standard conditions in semi-transparent polysulfone
(PSU) type III cages (PSU 80-1291HOOSU Type III, Tecniplast)
(15 × 27 × 43 cm) with Aspen wood chip bedding (Tapvei, Gentofte,
Denmark), Enviro Dri nesting material (Brogaarden, Lynge, Denmark)
and Tapvei Arcade 17 (Aspen wood) shelters (Brogaarden, Lynge,
Denmark). Environmental conditions were controlled with a 12-hour
light–dark cycle with light intensity 500 lx starting at 9 pm, humidity
55%±5, temperature at 21 °C ± 1 °C and ventilation changing air 10
times per hr. All animals were fed a standard diet with ALTROMIN
1314 (soy- and alfalfa-free, ALTROMIN GmbH, Lage, Germany).
Acidified tap water (to prevent microbial growth) in polysulfone bottles
(84-ACBTO702SU Tecniplast) was provided ad libitum. The polysulfone
bottles and cages, as well as the aspen wood shelters (instead of plastic),
were used to reduce the risk of migration of BPA or other plasticisers
that potentially could confound the study results.
The study was performed in three blocks (separated by one week),
and all dose groups were equally represented in the blocks (n = 18). On
the day after arrival (GD 4), dams were assigned to one of the seven
exposure groups (see table in Fig. 1) by a stratified randomization
scheme designed to achieve similar group mean body weights. A binary
mixture of DEHP and Procymidone (Amix), a binary mixture of BPA
and butylparaben (Emix), and a combination of all four compounds
(Totalmix) were tested in the same study. Details about the exact
mixture composition are given in a table in Fig. 1. The control group
was exposed to vehicle (corn oil). Each of the three mixtures was in-
vestigated in two dose groups (low and high).
Low and high doses of the mixtures were selected based on AGD
results in previous studies on single chemicals (Boberg et al., 2016;
Christiansen et al., 2014, 2010; Hass et al., 2012; Hass et al., 2007).
Low doses of each compound were found to induce reduced AGD by
around 5% in these studies and high doses were twice the low doses.
The two Total-mix doses equalled the sum of the low and high doses of
Amix and Emix, respectively. This experimental design was considered
as optimal for identifying potential effect modulations between both
binary mixtures.
Exposure was conducted once daily via gavage with a stainless-steel
probe 1.2 × 80 mm (Scanbur, Karlslunde, Denmark) at a constant
volume of 2 ml/kg bw/day (the individual doses were based animal
body weight on the day of dosing). Dams were dosed from GD 7 to PD
22 (day of delivery excluded). This exposure period was chosen to cover
sensitive periods of reproductive development. On GD 15 dams were
dosed first and then anesthetized with Hypnorm® (fentanyl citrate/
flunisone)/Dormicum® (midazolam), and blood was drawn from the
tail vein. Maternal plasma were stored at − 80 °C until analysis for
levels of DEHP, Procymidon, Bisphenol A and butylparaben. Dams not
giving birth were eliminated from the experiment.
At weaning of the offspring on PD 22, exposure to the test chemicals
was stopped for most of the examined offspring. One to two males and
females from each litter were kept for the examination of adult
Fig. 1. Overview of study. a) Individual compounds were examined in developing rats (see references in methods section), b) Mixtures were composed for the current
study, c) Design of the current study examining effects of the specified mixtures, d) A subset of animals was re-dosed during puberty and e) Data on AGD and nipple
retention were used for mixture modelling.
S. Christiansen, et al. Environment International 142 (2020) 105870
3
reproductive endpoints (N = 15–17). An additional sub-cohort of
weaned offspring from the control and both Totalmix groups
(N = 15–17, 1–2 males and females from each litter) were re-dosed
during peri-puberty, with females from PD 27–36 and males from PD
38–47, based on the timing of puberty in the two sexes. These groups
are designated as Re-Control, Re-Totalmix-high, and Re-Totalmix-low.
2.3. In vivo examination
He dams were inspected twice a day for general toxicity, including
changes in clinical appearance. Body weights were recorded on GD 4
and daily during the dosing period.
On the day after delivery PD1, all pups were counted, sexed,
weighed, checked for anomalies, and anogenital distance (AGD) was
measured. AGD was measured as the distance between the genital pa-
pilla and the anus by a stereomicroscope with a micrometer eyepiece.
The AGD index (AGDi) was calculated by dividing AGD by the cube root
of the body weight. All offspring were weighed on PD 6. On PD 14, all
male and female pups were weighed and examined for the number of
areolas/nipples (NR), described as a dark focal area (with or without a
nipple bud) located where nipples are normally present in female off-
spring. Normally, female rats have 12–13 nipples whereas male rats
have none. All in vivo examinations were performed blinded with re-
spect to the exposure group.
The onset of puberty was registered in all weaned male and female
offspring. In female offspring sexual maturity was assessed by de-
termining the day of vaginal opening (VO) as described by Goldman
et al., (2000), starting examination from PD 27. In male offspring, the
onset of puberty was assessed as the time of preputial separation (PPS)
starting examination from PD 38. On the day of VO or PPS the age and
weight of the animals were recorded.
2.4. Pup day 16–17 dissection
On PD 16, one male pup from each litter (N = 11–16) was weighed
and decapitated. Male offspring were examined for testicular descent
and reproductive organs were examined macroscopically for anomalies.
The testes, epididymides, ventral prostate, seminal vesicles, levator ani/
bulbo-cavernosus muscles (LABC), and bulbourethral glands were ex-
cised and weighed. Ventral prostate was placed in RNA later and frozen
for gene expression analysis. On PD 17, one female pup per litter
(N = 12–16) was weighed, decapitated and livers, ovaries, thyroid and
retroperitoneal fat pad was excised and weighed.
2.5. Pup day 22 dissection
Dams and PD 22 pups were weighed and decapitated in CO2/O2
anaesthesia. In dams, the number of uterine implantations was counted.
Testes and prostate were dissected and weighed from one male pup per
litter. From one female pup per litter, ovaries were dissected and
weighed, and mammary glands were collected for whole mount pre-
paration.
From one male per litter testes and ventral prostate was excised and
weighed, and mammary glands were collected for whole mount pre-
paration. Mammary glands were excised, placed on a glass slide, stained
with alum carmine. Whole mounts scanned on a flatbed scanner (4800
dpi) were evaluated for mammary outgrowth and extent of develop-
ment on the digital images using Image Pro Plus 7.0 software (Media
Cybernetics, Bethesda, Maryland) as described in Mandrup et al.
(2015). The number of terminal end buds (TEBs) was counted (defined
as tear-drop shaped buds in zone C with a diameter of 100 mm or more
(Russo and Russo, 1996). Additionally, a mean of scores (1 to 5) given
for each of the parameters area, number of buds, and number of
branches, branch generations, and TEBs were calculated.
2.6. Dissection of adult offspring
PD 83–87, the adult male offspring were weighed and decapitated in
CO2/O2 anaesthesia. Reproductive organs were examined macro-
scopically for anomalies. Weights of testes, liver, retroperitoneal adi-
pose tissue, epididymis (alternately left and right), and seminal vesicle
including coagulating glands and prostate were determined. In addi-
tion, the ventral prostate was weighed separately. Ventral and dorso-
lateral prostate were fixed in formalin before processing for paraffin
Fig. 2. Adverse outcome pathways in male reproductive toxicity. We propose that mixture risk assessment is based on information from all parts of the adverse
outcome pathways so that substances for which only in vitro data is available are grouped with substances for which only in vivo effect data are available, when these
data indicate effects on the same mode of action. This figure illustrates adverse outcome pathways leading to impaired fertility and increased risk of endocrine-
sensitive cancers. Diverse classes of chemicals can influence these pathways, and the current study shows how four chemicals acting via different modes of action.
The four chemicals are included in ovals indicating which effects are known to be exerted by each chemical. Combination of these four compounds leads to
exaggerated effects on adverse outcomes. Boxes lined by fat lines indicate effects observed in vivo in the current study. The most marked effects were seen with
combined exposure to all four compounds. ButPar = butylparaben, Procy = Procymidon.
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embedding. Tissue was sectioned (3 µm), stained with hematoxylin and
eosin and examined by light microscopy (blinded with respect to
treatment group). Histological examination of the prostate was per-
formed on animals from the control, Re-Control and Re-Totalmix-high
group, as well as from all high dose mixture groups (Amix-high, Emix-
high and Totalmix-high). One section per animal was examined. The
dorsolateral prostate was examined with an emphasis on inflammation
and interstitial, intraluminal and total inflammation was scored 0–3,
0–4 and 0–4, respectively relative to the severity of inflammation.
Ventral prostate was evaluated with a focus on inflammation, epithelial
hyperplasia, and epithelial atrophy as described by Isling et al. (Isling
et al., 2014).
Alternately left or right cauda epididymis including 1 cm of ductus
deferens was frozen in liquid nitrogen and stored at −80 °C for sperm
count analysis. The cauda epididymis was thawed, weighed and pre-
pared as described previously (Jarfelt et al., 2005) using computer-as-
sisted sperm analysis (CASA). A DNA-specific stain and fluorescence
illumination was used to identify sperm cells. The average value of the
three counts is presented as number of sperm per gram cauda.
At PD 80–90, all the females were sectioned when in estrous and
examined macroscopically for external anomalies in the reproductive
organs. Uterus, ovaries, retroperitoneal fat pads and liver were dis-
sected and weighed.
2.7. Gene expression
On PD 16, prostates from 13 to 15 males/exposure group were
isolated and stored in RNAlater (Qiagen, Hilden, Germany) at −80 °C.
Total RNA was isolated using RNeasy MiniKit (Qiagen, Hilden,
Germany), quantified on a NanoDrop 1000 Spectrophotometer, and
cDNA synthesized with the Omniscript RT kit (Life Technologies Europe
BV, Naerum, Denmark). The gene text is provided in the supplementary
file (S-1).
2.8. Chemical analysis in serum from dams
Chemical content was analysed in plasma samples from dams at GD
15 (N = 6, pooled from 1 to 3 dams). The dams were dosed first and
anesthetized and blood was drawn from the tail vein approximately an
hour after dosing. The description of the chemical analysis is given in
Supplementary (S-1).
2.9. Mixture modelling
The effects of the mixtures were estimated according to the prin-
ciple of dose addition (DA) under the assumption of non-interaction
between the compounds (Greco et al., 1995): the dose of the n-com-
pound mixture causing x% effect (EDxmix) is calculated from the EDx for
each individual compound leading to the same response X and the re-
lative dose contribution pi of each compound i to the mixture (Faust
et al., 2003) as




















Accordingly, dose-additive mixture doses were calculated for all
three mixtures on the basis of the individual compounds. The EDx for
the four compounds were estimated from historical data obtained under
similar testing conditions (Boberg et al., 2016; Christiansen et al., 2014,
2010; Hass et al., 2012, 2007) (Table S6). For a non-effective com-
pound, the term pi/EDxi in Eq. (1) was set to zero If a compound did not
reach an x% effect level the estimation of its corresponding effect dose
EDx is not possible, and, consequently, an EDxmix cannot be calculated
for the mixture according to Eq1. In this case, we followed the dose
extrapolation approach for DA predictions (Scholze et al., 2014) which
provides a range of worst-case predictions for the mixture dose EDxmix:
the compound’s pi/EDxi in Eq. (1) is assumed to be between zero (no
contribution) and the highest value of pi/EDxi that can be derived ac-
cording to Eq (1) at any of the lower mixture concentrations (maximal
contribution). Consequently, the lower mixture response prediction
corresponds to the “zero” contribution of the compound(s), and the
higher response to the “maximal” contribution. In addition, we esti-
mated from the dose–response data of the two binary mixtures (Amix,
Emix) their effect doses which then were used as input data to calculate
the expected effect dose for the four-compound mixture (Totalmix), i.e.
the two binary mixtures were treated as two individual compounds in
Eq. (1). It should be noted, that the binary mixtures were tested only at
two doses, and consequently, the outcomes of their regression model-
ling should be considered with caution at doses outside the tested dose
range.
To account for the statistical uncertainty in the DA prediction, a
combined Monte-Carlo (MC) and nonlinear regression bootstrap simu-
lation was conducted to establish approximate 95% confidence limits
around the predicted mean mixture response: for each compound a
distribution of resampled model fits was simulated by parametric
bootstrap with resamples drawn from the fitted nonlinear (mixed) effect
model (Efron and Tibshirani, 1993) which then was used as input for
MC to generate a distribution of mixture prediction. Differences be-
tween predicted and observed mixture effects were deemed statistically
significant when the 95% confidence belts of the prediction did not
overlap with those of the experimentally observed mixture effects.
2.10. Statistical analysis
For all analyses, litter was the statistical unit. When more than one
pup from each litter was examined, statistical analyses were adjusted
using litter as an independent, random and nested factor. AGD and
organ weights were analysed using body weight as covariate, and birth
weights were analysed using the number of offspring per litter as cov-
ariate. Body weight in all animals PD 6, 14 and 22 were analysed in a
mixed linear model including dose group and sex. All dose-related ef-
fect changes on continuous endpoints were analysed by ANOVA
methods (mixed effect modelling), and statistical significance was as-
sessed using multiple contrast tests (Bretz et al., 2005). Robustness of
data analysis was supported by outlier and influence analysis, and if
necessary data analysis was repeated on basis of winsorized means, a
mean estimation method that is relatively insensitive to outliers: 2.5%
of the lowest and 97.5% of the highest observations per dose group are
replaced by their group-specific 2.5% and 97.55 percentiles, which
minimizes the impact of extreme values. The statistical significance that
was achieved only after data winsorization is reported accordingly. The
quantal distribution of sperm was considered as sufficiently close to the
continuous Gaussian distribution, and therefore this endpoint was
analysed by the same ANOVA methods as mentioned before. In the case
of animals with abnormally low sperm counts (not exposure related),
data analysis was repeated without their counts. The number of nipple/
areolas (NR) was assumed to follow a binomial-distribution with a re-
sponse range between 0 and 12, with the latter assumed to reflect the
biologically possible maximal number of nipples in rats. Litter effects on
NR and over-dispersion in the data were accounted for by using Gen-
eralized Estimating Equations (GEE) as reported in (Christiansen et al.,
2012). Fisher’s exact test or chi-square test was used for statistical
evaluation of prostate histopathology. Time-to-Event data endpoints
(day of sexual maturation) were analysed by Kaplan-Meier methods,
with general dose-related pattern identified by a trend test and paired
mean differences between controls and dose group by the nonpara-
metric Wilcoxon test under the control of p-value adjustments ac-
cording to Dunnett-Hsu (Hsu, 1992). All remaining non-continuous
endpoints (e.g. percentage post-implantation loss) were analysed by the
non-parametric Dunn’s Multiple Comparison Test. These analyses were
performed in GraphPad Prism 8 (GraphPad Software, San Diego, CA,
USA). All pairwise statistical testing referred to the Null hypothesis “no
S. Christiansen, et al. Environment International 142 (2020) 105870
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difference between control and exposure mean” which was rejected if
the p-value was below the false-positive rate of 5%. The experimental
design ensured the statistical detection of at least a 10% change for the
endpoints AGD and NR (assuming error rates of α= 5% and β= 20%).
Direct comparison of effect means between two exposure groups was
analysed by the same models and methods as described before. Dose-
response regression analysis was performed by a best-fit approach
(Scholze et al., 2001) where various nonlinear regression models were
fitted to the same data set and the model that describes data best was
selected. All statistical analyses were conducted in SAS (SAS Enterprise
Guide 4.3).
3. Results
Overall, this study showed that developmental exposure to a com-
bination of anti-androgens and estrogens can lead to effects on endo-
crine-sensitive endpoints that cannot be explained by the binary mix-
tures of anti-androgens or estrogens alone and therefore should be
considered as combination effects. Specifically, male AGD and seminal
vesicle weight were significantly more reduced in the four-compound
mixture group (Totalmix) than in each of the binary mixture groups
(Emix and Amix). The same was seen for nipple retention, which was
significantly higher in the Totalmix group than in the binary mixture
groups. Also, effects on other endpoints including sperm count ap-
peared most marked in the Totalmix group, indicating the presence of
combination effects between estrogens and anti-androgens.
3.1. Pregnancy data, postnatal growth and general toxicity
There were no statistically significant effects of dosing on maternal
body weight gain in gestation or lactation, no change in gestation
length, post implantation-loss and litter size. Pup body weights were
unaffected at the examined ages (Table S-2). No macroscopic anomalies
or undescended testes were seen at any of the examined ages in the
males and no genital malformations were seen in the female offspring.
3.2. Anogenital distance (AGD) and nipple retention
Both high and low mixture doses of Totalmix and Amix significantly
decreased AGD at birth in male offspring (p < 0.05), with the AGD
reduction at Totalmix-high being slightly more marked than at Amix-
high (p < 0.05, Fig. 3A and Table S-2). AGD reductions were also
observed in female offspring, with both doses of Amix and the high dose
of Totalmix having significantly reduced AGD (Table S-2).
he observed AGD responses of Totalmix agreed well with the dose-
additivity curve that was derived from the AGD data observed for Amix
and Emix, with both binary mixtures expressed as regression curves for
the additivity calculation (Fig. 3C, Table S5, with AGD always ex-
pressed as relative AGDI). In Fig. 3C we have added the regression
curves for both binary mixtures, and for a better comparison to the
additivity curve both were scaled to the mixture concentration: the
additivity curve is nearly identical to the Amix curve, and from this
comparison it is unclear whether the Emix compounds contributed to
the observed Totalmix responses. If we used historical dose–response
AGDI data of each compound to generate a prediction curve for ad-
ditivity (Table S6), we achieved a good agreement between observed
and predicted mixture responses (Fig. 3E). As we observed in previous
studies on BPA and Butylparaben only AGDI reductions up to 15%, the
DA prediction curve can be generated according to Eq. (1) only to this
effect level. Therefore mixture responses beyond a 15% AGD reduction
were predicted by the toxic unit extrapolation method (Scholze et al.,
2014) which makes worst-case assumptions for the expected contribu-
tion of these two compounds to the overall mixture response, and as
consequence generates a range of possible prediction values.
Nipple retention in male offspring was significantly increased both
low and high dose mixture groups of Amix and Totalmix (Fig. 3B).
When the Amix was tested in combination with the Emix, Totalmix
produced significantly higher numbers of nipples and areolas than ob-
served for Amix alone (Fig. 3B). This suggests that the Emix enhanced
the effect of the Amix.
An additivity expectation derived from Emix and Amix was ham-
pered, as the Emix did not induce nipple retention within the dose
range tested. Assuming that at higher doses of Emix we would have
seen also no effects, we expected the observed mixture responses from
the four compounds to equal the responses from the Amix. However,
the observed number of nipples/areolas at Totalmix exposure were near
twice the responses observed at Amix (Fig. 3D). In contrast, if the
prediction curve for additivity was based on single substance dose–r-
esponse data from previous studies, we got an excellent agreement
between predicted and observed mixture responses (Fig. 3D). Similar to
the additivity curve in Fig. 3D, we did not expect a contribution from
the estrogenic compounds to the overall mixture response, as only
procymidone and DEHP were active (Christiansen et al., 2010; Hass
et al., 2012, 2007) but not BPA and butylparaben at these doses (Boberg
et al., 2016; Christiansen et al., 2014). Therefore, the agreement be-
tween observed and expected dose additivity seems to depend on
whether data of the single substances or their binary mixture outcomes
were used. As only Amix was tested in parallel to Totalmix, but not the
individual compounds, we cannot rule out that either procymidone or
DEHP (or both) were less active than expected from previous studies,
and predictions based on historical dose–response data for procymi-
done and DEHP, therefore, overestimated their additive response
(Fig. 3D). Alternatively, the combined action of the two anti-androgenic
compounds on NR did not follow dose addition, which would contradict
previous studies on these compounds (Christiansen et al., 2008; Hass
et al., 2007; Rider et al., 2009). From an additivity point of view, it is
thus likely that either BPA or butylparaben (or both) must have en-
hanced the mixture response from Amix.
3.3. Offspring body weights and puberty timing
Offspring body weights on PD 6, 14 and 22 showed no difference
with respect to dose groups or sex when analysing all pups per litter
(data not shown).
In the subset of females sectioned at PD22, female body weights
were decreased by both doses of Totalmix (Table S-4).
In males, sexual maturation was slightly delayed, indicating hor-
mone-dependent effects. Re-dosing during puberty did not affect the
time of sexual maturation, and therefore further analyses comprised all
animals, i.e. both those exposed only perinatally and those re-dosed
during puberty. In males, the mean day of sexual maturation was sig-
nificantly delayed by 1.5 days at both Emix-low and the high dose of
the Totalmix compared to controls (control: PD = 44.6, Emix-low:
PD = 46.0, Totalmix-high: PD = 46.1). When analysing this time-
course data (day of sexual maturation in males) as fractions, statistical
significance was obtained in both in Emix-low compared to controls
(p = 0.0115) and Totalmix-high compared to controls (p = 0.022)
(Table S-2 and Fig. 5A). In females, the mean day of sexual maturation
appeared to be one day delayed in the groups exposed to the two doses
of the Totalmix compared to controls (control PD31.8, Totalmix-low PD
32.8 and Totalmix-high PD 33.0), but the differences were not statis-
tically significant (Table S-2). There were no significant effects on body
weight on the day of sexual maturation of males or females.
Male body weights at PD 80 were unaffected by the exposure in
animals exposed only perinatally (Table S-5). Males re-dosed with the
Totalmix during puberty had lower body weights at PD 80 than con-
trols, though the effect was more marked in the low than the high dose
of the Totalmix (Table S-5). In female offspring exposed perinatally,
body weights were decreased on PD 80 by all doses except Amix-high
(Table S-4). In contrast, females re-dosed with the Totalmix showed no
significant changes in body weights at PD 80 (Table S-5). For both
males and females there were no statistically significant differences
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between groups exposed only perinatally and groups re-dosed in pub-
erty, indicating that re-dosing did not have a major influence on body
weights.
3.4. Mixture effects on reproductive organ weights
Organ weights were examined at PD 16, 22 and 80. In prepubertal
males, the Totalmix and some sub-mixtures reduced the weights of most
male reproductive organs (Fig. 4B-F, Table S-3). In contrast, the high
doses of Amix and Totalmix increased testis weights (Fig. 4A). On PD
16, when dosing was ongoing, the Amix decreased the weight of epi-
didymides, LABC, bulbourethral glands and the ventral prostate. The
Emix decreased the weight of LABC and bulbourethral and adrenal
glands, and the Totalmix decreased the weight of epididymides, seminal
Fig. 3. Anogenital distance (AGD) and nipple retention in male rats exposed perinatally to mixtures of endocrine disrupters. Blue dots are litter means and red
diamonds are group means. A mixture of DEHP and procymidone (Amix) reduced anogenital distance (A) and increased the number of nipples/areolas (B). No effects
were seen for a mixture of bisphenol A and butylparaben (Emix), but marked effects were seen when all four substances were combined to a Totalmix (A, B). Asterisks
indicate statistically significant differences from controls, and horizontal bars illustrate that the effects of the Totalmix were significantly different from the effects of
the Amix. Significance level p < 0.05. Observations on AGD index showed good agreement with dose-additivity expectations calculated on the basis of data from the
Amix and Emix groups (internal study data, green line, C) and predicted on the basis from historical data (external study data, E). In contrast, the observations for
nipple retention were underestimated when dose-additivity was derived from Amix (D), but in good agreement when predicted from historical data (F). To achieve
comparability to the dose scale of Totalmix, doses of Amix and Emix were rescaled by 1.4 and 3.5, respectively (C, for mixture composition, see Fig. 1). All data
shown in C-F refer to Totalmix, and the additivity prediction in panel D equals the regression curve of Amix. Dotted horizontal lines indicate values for control males
and females respectively. Dose additive AGD responses were estimated at high doses according to the toxic unit (TU) extrapolation method. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
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vesicle, LABC, bulbourethral glands and the ventral prostate (Fig. 4B-F,
Table S-3). At this age, the effect of the Totalmix was significantly more
marked than the effect of the Amix or the Emix on seminal vesicle
(Fig. 4C, Table S-3).
In adulthood (at PD 80), a reduction in epididymis weight was still
present in Amix and Emix groups (Table S-3), and also in the Totalmix-
low group when data from perinatally exposed animals and re-dosed
animals were combined (Table S-5). A reduction in ventral prostate
weight persisted in the Totalmix group but was only statistically sig-
nificant in the re-dosed animals (Table S-5).
Interestingly, the high dose Amix group increased prepubertal testis
weight more markedly than the high dose Totalmix group at 16, 22 and
80 days of age (Table S-3), and together with the significantly lower
reduction observed at the Emix-high group on PND80, this indicates
opposing effects of Emix and Amix on this endpoint.
3.5. Sperm counts reduced by all mixtures
Epididymal sperm counts were significantly reduced in all mixture
groups (Fig. 5E, Table S-3 and S-5, p < 0.01). As no statistically sig-
nificant effect of re-dosing was seen, the analyses of sperm count were
performed on all animals, i.e. combining animals exposed only
Fig. 4. Male reproductive organ weights at PD 16 were affected by perinatal exposure of rats to a mixture of DEHP and procymidone (Amix), a mixture of bisphenol A
and butylparaben (Emix), and a Totalmix of all four substances. Blue dots are litter means and red diamonds are group means. Asterisks indicate statistically
significant differences from controls, and horizontal bars illustrate that the effect of the Totalmix on seminal vesicle weight was significantly different from the effects
of the Amix. For mixture composition, see Fig. 1. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this
article.)
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perinatally and those re-dosed during puberty. The most marked re-
ductions in sperm count were seen in the Totalmix-high group but this
effect was not significantly different from effects in Emix-high or Amix-
high groups. One animal in the control group and three animals in the
Totalmix-low group had very few sperm cells compared to all other
animals in the study. This pattern with a few animals showing much
lower sperm counts has been seen in previous studies from our la-
boratory and has been reported irrespective of dose. Statistical analysis
was performed both including and excluding these four outliers, and
the same pattern of effect was seen in both analyses (data excluding
Fig. 5. Endocrine-sensitive processes and tissues in rats after perinatal exposure to a mixture of DEHP and procymidone (Amix), a mixture of bisphenol A and
butylparaben (Emix), and a combination of all four substances (Totalmix). In offspring, the Totalmix delayed preputial separation (A, evaluated in two males per
litter, N = 15–17 litters per dose group) see also Table S-2 for mean values. Fraction means the number of animals displaying preputial separation out of the total
number of animals. At PD 16, expression of androgen-regulated gene CYP17b1 was reduced in ventral prostate (B, N = 13–15, mean + SEM). At PD 22, hormone-
sensitive development of mammary glands was identified as an increase in the number of Terminal End Buds (D, N = 11–13, mean + SEM). In adult offspring,
Totalmix-exposed animals displayed histological changes in prostate (C, N = 15–17), and all mixture groups displayed significantly reduced sperm counts (E,
evaluated in two males per litter, n = 15–17 litters per dose group, mean + SD). Asterisks * indicate statistically significant differences from controls, *:p < 0.05,
**: p < 0.01. Hashtags # indicate statistically significant differences from controls, p < 0.01, when combining animals exposed only perinatally and those re-dosed
during puberty. For mixture composition, see Fig. 1.
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outliers not shown).
3.6. Early markers of late effects on prostate
Early changes in prostate development were evidenced by reduced
organ weights and reduced expression of the AR regulated gene Cyp7b1.
Both Totalmix groups showed significantly lower ventral prostate
weights at PD 16 and 22 compared to controls and also significantly
lower than prostate weights at corresponding doses of Amix or Emix
individually. This indicates combination effects of Amix and Emix
(Fig. 4F). The expression of the AR-regulated gene Cyp7b1 was sig-
nificantly downregulated in the Totalmix-high group on PD 16
(p = 0.01, Fig. 5B). No effect was seen on the AR-regulated genes
Pbpc3, Odc, Trpm2, nor on Esr2. Gene expression was not affected by
any of the binary mixture groups, which may reflect a combined effect
of the four compounds of the Totalmix.
Histological examination of the dorsolateral prostate of adults
generally revealed large variations in prostate morphology within all
dose groups. Some indications of long-term effects were seen, as the
highest scores (2–3) for interstitial inflammation in dorsolateral pros-
tate were observed in the Totalmix-high group, but not in controls
(Fig. 5C). Examination of ventral prostate histopathology showed no
statistically significant differences between exposed high dose mixture
groups and controls or between the Totalmix-high and Re-Totalmix-
high groups (data not shown). Variable degree of interstitial and in-
traluminal infiltration, epithelial atrophy, and epithelial hyperplasia
were observed in all groups. Reactive epithelial hyperplasia with the
presence of variable degree of cellular atypia was observed in 14 males
with moderate total inflammation (score 3) and in 13/36 males with
moderate total inflammation (score 2) from different dose groups.
3.7. Mixture effects on mammary development
Prepubertal mammary glands were affected in both males (Fig. 5D)
and females (data not shown), as a significantly higher number of TEBs
was seen in the Totalmix compared with controls. No significant effects
on these endpoints were seen for either the Amix or the Emix groups,
indicating the mixture effects of anti-androgens and estrogens. No ef-
fects were seen in males or females on outgrowth measures (area,
growth towards the lymph node, longitudinal growth) or in a score
combining information on branching, duct number, area and TEB
number.
3.8. Chemical analysis of maternal plasma
Chemical analysis confirmed the presence of the parent compounds
or main metabolites in the dosed animals. The plasma concentrations of
procymidone and the DEHP metabolites from the dams were around
twofold higher in the high concentration mixture groups than in the
corresponding low concentration mixtures (Fig. 6) and thus in pro-
portional agreement with the intake doses. Their concentrations were
roughly the same in the Amix and Totalmix, but slightly lowered in the
Totalmix-high groups when compared to the Amix-high group. These
patterns were not confirmed for BPA or butylparaben, as all groups
showed comparable concentrations.
4. Discussion
We show that developmental exposure to combinations of chemicals
with different endocrine modes of action can lead to enhanced adverse
effects on the developing and adult reproductive system in rats. We
found no experimental evidence against describing the mixture effects
on AGD and nipple retention as dose-additive. As illustrated in an AOP
framework (Fig. 2), different molecular initiating events can lead to the
same adverse outcomes, and we propose that substances with mixed
endocrine modes of action should be grouped together in mixture risk
assessment.
4.1. Early exposure to EDCs with mixed modes of action leads to late-life
adverse health effects
We demonstrated that a mixture of DEHP and procymidone (Amix)
induced nipple retention and shortened AGD in developing male rats,
whereas a mixture of BPA and butylparaben (Emix) did not. All four
compounds combined (Totalmix) showed more marked effects than
seen for the Amix alone. The same pattern was seen for prepubertal
male reproductive organ weights, which for seminal vesicles was sig-
nificantly lower in the Totalmix group than in the Amix and the Emix
groups. These early markers of endocrine disruption can be considered
predictors of late-life adverse effects, as in adulthood the Totalmix
showed the most marked effects on sperm count and prostate histo-
pathology. Overall, we suggest that the Emix exposure potentiated the
effects of the Amix by direct endocrine action on target tissues (Fig. 2).
Even though the Emix alone did not affect AGD or nipple retention, the
endocrine activity of this mixture was evident from the lower sperm
counts and reduced weights of LABC and bulbourethral gland. BPA was
present in the mixture at a dose that caused an AGD reduction in our
previous study (Christiansen et al., 2014) and has been reported for its
reproductive toxicity in males (EFSA, 2015). Nevertheless, many other
studies have reported first signs of male reproductive toxicity at much
higher dose ranges (EFSA, 2015; Tinwell et al., 2002; Tyl et al., 2008,
2002). We speculate that a similar study with higher doses of BPA or
using another estrogenic model compound - would show even clearer
evidence of additive effects on male reproductive development.
4.2. Lack of toxicokinetic interference
An alternative explanation to the potentiation of Amix responses by
Emix could be toxicokinetic interference. It could be speculated that the
presence of Emix would reduce or delay the elimination of Amix
components and thus increase their bioavailability and effect responses.
However, chemical concentrations in dam plasma at GD 15 did not
support this explanation, as concentrations of procymidone, MEHP (the
main and active metabolite of DEHP in serum and plasma (Martino-
Andrade and Chahoud, 2010) and other DEHP metabolites were slightly
lower in the Totalmix-high group than in the Amix-high group. Con-
sidering the common endocrine targets of these substances, the marked
effects in the Totalmix-high group was thus attributed to the combined
effects of all four compounds.
BPA and butylparaben in the serum were present at similar con-
centrations in low and high dose Emix-groups. The identical con-
centrations of butylparaben in maternal plasma in all dose groups echo
our earlier rat studies showing similar concentrations of butylparaben
at different doses in maternal plasma, but increasing concentrations
with higher doses in amniotic fluid (Frederiksen et al., 2008). In ad-
dition, butylparaben levels in amniotic fluid were significantly higher
than in maternal plasma (Frederiksen et al., 2008). In this study, no
fetal blood or amniotic fluid samples were available for further analysis,
but an investigation of fetal internal exposures and time-course data
would be necessary to investigate further the relationship between
administered doses and internal exposures to these chemicals. Finally,
the detailed metabolism and excretion pattern in rats for all four che-
micals remains to be studied for different mixture concentrations.
4.3. AOP-based grouping for mixture risk assessment
The current findings of combination effects of chemicals with dif-
ferent mechanisms of action highlight the importance of performing
mixture risk assessment by grouping compounds with effects on the
same targets and not only by grouping compounds with similar modes
or mechanisms of action (Boberg et al., 2019). We suggest using
knowledge on AOPs to define broader groups of chemicals for inclusion
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in the mixture risk assessment than groups limited to either chemicals
with “shared target organs” or with “shared mode of action”. AOP
based grouping will thus enable mixture risk assessment of more che-
micals including those for which data are scarce and only either in vitro
mechanistic data or in vivo effect data are available. We thus provide
evidence for suggestions by EFSA (2019) to use the knowledge on AOP
for mixture risk assessment. Specifically, we propose that substances
acting on male reproductive target tissues should be grouped with
substances that have been shown to be estrogenic and/or anti-andro-
genic in vitro. Generally, the same approach could be taken for sub-
stances with other endocrine or non-endocrine targets: substances
known to act on molecular targets at one end of an AOP should be
grouped with substances acting on endpoints at the other end of the
same AOP. For example, a substance acting as an AR antagonist for
which no in vivo data are available should be grouped with a substance
reducing male AGD for which no information on mechanism of action is
known.
4.4. Predicting mixture effects from internal study data or historical data
Dose-additivity predictions of the four-compound mixture
(Totalmix) were calculated on basis of (i) binary mixture outcomes
from the current study and (ii) single compound dose–response data
from studies conducted earlier in our lab (Boberg et al., 2016;
Christiansen et al., 2014, 2010; Hass et al., 2007), and their predictive
power then assessed by comparing them to the observed mixture re-
sponses.
For AGD we found no clear experimental evidence against ad-
ditivity. However, only weak AGD reductions were observed in pre-
vious studies for BPA and Butylparaben, which limited a priori the
assessment range for AGD responses. According to the principles of dose
addition, we furthermore expected a high contribution of procymidone
and DEHP to the overall mixture additivity, which prevented clear
discrimination between the binary mixture responses and their ex-
pected overall additivity. Therefore, it remains unclear whether the
combined action of both anti-androgenic and estrogenic compounds on
AGD can be described always by dose addition.
Mixture effects on nipple retention provided a better basis for an
assessment as BPA and Butylparaben showed neither individually nor in
combination effects. Therefore, the suitability of the dose addition
model was reduced to the question of whether procymidone and DEHP
were able to describe the observed mixture effect of Amix in the pre-
sence of Emix. The effects in the Totalmix were accurately predicted on
the basis of historical single compound data, but slightly higher than
the responses observed by Amix.
These experimental findings cannot readily point out whether
mixtures of chemicals with diverse endocrine modes of action can cause
mixture effects on hormone-sensitive endpoints that can be described
accurately by dose addition. However, we found no experimental evi-
dence against using dose addition as a regulatory worst-case reference
as all predictions derived from historical data either agreed well or
slightly overestimated the observed mixture responses but did not un-
derestimate them. When aiming to protect humans against adverse ef-
fects of chemical exposures, the overestimation of predicted mixture
effects may lead to a higher level of protection. From a public health
viewpoint, such conservative estimates may be acceptable.
4.5. Multiple modes of action leading to adverse reproductive effects
A long-term adverse effect on sperm count was seen in all dose
groups, most markedly in the high dose Totalmix. This highlights that
chemicals with mixed modes of action can target the same organ even
long after the last gavage exposure.
Male reproductive effects were alerted already in pre-puberty when
mainly the Totalmix reduced weights of accessory reproductive organs
(epididymis, prostate, seminal vesicle). These early marker tissues are
known to be affected by anti-androgenic substances(Christiansen et al.,
2010; Jacobsen et al., 2012). Combination effects of anti-androgenic
substances in vivo have also been shown by other research groups
(Conley et al., 2018; Howdeshell et al., 2008b; Rider et al., 2008). In-
terestingly, Emix decreased the weight of androgen-dependent tissues
LABC, bulbourethral glands and epididymides. This may support an
anti-androgenic effect of these two compounds when administered to-
gether, however, no such effects were seen in historical data from our
Fig. 6. Chemical concentrations were ana-
lysed in plasma samples from dams at GD 15
(N = 6, pooled from 1 to 3 dams) see Fig. 1.
Higher concentrations were seen of procy-
midone, nmol/mL (A) and the DEHP meta-
bolite MEHP, ng/mL (B) in the Amix-high
group than in the Amix-low group. Plasma
concentrations of Amix chemicals were
lower in the Totalmix-high group than in the
Amix-high group (p = 0.03 and p = 0.04
for MEHP and procymidone, respectively).
The sum of five DEHP metabolites, ng/mL
(C) did not show significant difference be-
tween Totalmix-high and Amix-high groups.
For BPA (D) and butylparaben, ng/mL (E)
no significant differences between Emix and
Totalmix groups were seen. Data is shown as
mean values.
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laboratory on the single compounds BPA and butylparaben (Boberg
et al., 2016; Christiansen et al., 2014). In line with this, a study on the
structurally related propylparaben showed clear evidence of an anti-
androgenic effect in the Hershberger assay (Özdemir et al., 2018),
however, no data are available from Hershberger studies on butylpar-
aben.
Early fetal testis development is largely androgen-independent
while the accessory reproductive organs and especially spermatogenesis
is completely dependent on androgen signalling (Sharpe, 2006). Inter-
estingly, prepubertal testis weights were increased rather than reduced
by the Amix, and the Emix appeared to counteract the effect of Amix on
testis weights when combined in the Totalmix. Increased testis weight
was also seen with exposure to procymidone alone at similar doses
(Jacobsen et al., 2012; Metzdorff et al., 2007). Possibly, procymidone
reduces the normal negative feedback on follicle-stimulating hormone
(FSH), a key regulator of Sertoli cell proliferation and in turn testis size
(Atanassova et al., 2005). The resulting increase in testis weight ap-
pears to be normalized by Emix, and this corresponds with the
knowledge that neonatal estrogen exposure delays testis development
and reduces testis weight (Atanassova et al., 2000).
Prostate development is sensitive to estrogenic as well as anti-an-
drogenic chemicals that may induce ventral prostate inflammation
(Cowin et al., 2008; Stoker et al., 1999). In the current study, Totalmix
exposure affected the androgen-sensitive gene Cyp7b1 in developing
prostate (Metzdorff et al., 2007; Tang and Norlin, 2006). Cyp7b1 is
considered a key regulator maintaining the balance between AR and ER
signalling in the prostate (Tang and Norlin, 2006), and the current re-
sults emphasize a possible role of this factor as an early marker of
changes through both ER and AR related pathways. In adult offspring,
signs of increased incidence of epithelial inflammation were seen after
Totalmix exposure. An increased incidence of prostatic lesions has
previously been seen in young adult rats after perinatal or neonatal
exposure to estrogenic compounds (Howdeshell et al., 2008a; Prins
et al., 2007) and may be related to pre-cancerous lesions in humans.
Examination of the prostate from older rats could further elaborate on
whether the present mixtures would induce atypical hyperplasia later in
life.
Early mammary gland development of males was affected by the
Totalmix, as the number of TEBs was increased. This indicates an ac-
celerated development of mammary glands, possibly due to an altered
androgen/estrogen balance, and was also seen in females. Previously,
we have seen an increased TEB number in males with exposure to the
potent estrogen ethinyl estradiol (Mandrup et al., 2012). TEBs are the
site of origin of mammary carcinomas and a target structure of carci-
nogens (Russo and Russo, 1996). An increased number of TEB for a
longer period of time may be related to an increased sensitivity to
carcinogenic insults and thus a higher cancer risk later in life, as seen in
female rodents (Fenton, 2006). It should be noted that also men get
breast cancer, and that increased breast development in men (gyneco-
mastia) is frequently observed (Sansone et al., 2017). Examination of
early mammary gland development in males may be useful as a sensi-
tive marker of long-term adverse effects on the mammary glands, as
already proposed in an OECD test guideline for reproductive toxicity
(OECD, 2018; Osborne et al., 2015).
4.6. Re-dosing during puberty
Puberty is a sensitive developmental window and pharmaceutical
and environmental compounds may alter pubertal development (Stoker
et al., 2000). The re-dosing of males and females during puberty pro-
vided no indications for changes in the puberty timing or sperm counts.
However, the period of re-dosing applied was initiated later than sug-
gested by protocols for pubertal assays of the US Environmental Pro-
tection Agency’s Endocrine Disrupter Screening Program (Stump et al.,
2014), which recommends the re-dosing starts at weaning (PD 22). In
this study, the re-dosing started at PD 27 and 38 in females and males
respectively and this could have affected the results. Nevertheless,
weights of seminal vesicle and prostate from male animals that were re-
dosed with the Totalmix doses during puberty were slightly more de-
creased than in only perinatally exposed animals. This finding reached
statistical significance when related to the controls (Supplementary
Table S-5). Therefore, we cannot rule out that additional peripubertal
exposure can have an additional impact on reproductive endpoints. Less
clear were the findings for other endpoints, but the statistical sig-
nificance detected for epididymal weight changes when data from both
the re-dosed and non re-dosed animals were pooled (using litter as the
statistical unit) may indicate that higher sample sizes would have re-
vealed a clearer picture about subtle effects on reproductive organ
weights.
5. Conclusions
Combined exposure to both anti-androgens and estrogens leads to
effects on anogenital distance, sperm count and several other re-
production endpoints. Generally, the presence of estrogenic compounds
enhanced the effects observed for the anti-androgens, suggesting that
this potentiation was caused by direct endocrine action on target tis-
sues. This is supported by internal concentration measurements which
provided no evidence for toxicokinetic interaction as a possible ex-
planation.
Dose-additivity predictions derived from historical data for ano-
genital distance and nipple retention agreed relatively well with the
observed mixture effects, and the deviations observed for these mix-
tures can be considered as acceptable from a regulatory point of view.
However, the experimental evidence from this study is too limited for
general conclusions and mixture studies with other compounds are
necessary to explore how well the combined action between anti-an-
drogens and estrogens can be described by dose-addition. The lower
sperm counts observed at all mixture exposures and the reduced adult
male reproductive organ weights identified after exposure to both anti-
androgens and estrogens (particularly in animals re-dosed during
puberty) lead us to conclude that the exposures produced long-term
adverse health effects in rats.
Our proof-of-concept study demonstrated that combination effects
between anti-androgens and estrogens are possible, and if ignored may
lead to an underestimation of risks associated with exposures to che-
micals that disrupt male sexual differentiation. Since unhindered en-
docrine action is essential for human development, these findings are
highly relevant to human risk assessment.
6. Perspectives
Our study provides an example of a mixture scenario where several
modes of action can converge into a common adverse health outcome.
This supports the view that cumulative assessment groups for the
mixture risk assessment should be defined along all shared AOPs that
can affect the adverse health outcome (Boberg et al., 2019;
Kortenkamp, 2020). We propose that mixture risk assessment should be
conducted even for compounds with sparse data as long as sufficient
information is available that indicates a potential interruption to key
events of at least one of the relevant AOPs. For some compounds, we
may only have information on early events from in vitro/in silico studies
while for others we only have observations on an adverse outcome in
vivo, and all should be grouped for mixture risk assessment (Fig. 2).
Beyond endocrine disruption, this has a major impact on regulatory
decision-making and is an important contribution to current work by
regulatory authorities worldwide concerning enforcing mixture risk
assessment as an essential step towards human chemical safety.
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